Lexpos News

MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) Drug alert number: EL(26)A/18 Date issued: 30 March 2026 Bio Products Laboratory Limited is recalling one batch of Human Rabies Immunoglobulin following a stability failure for this batch. The batch has shown a reduction in potency of the [...]

The post MHRA Class 2 Medicines Recall: Rabies, Human normal Immunoglobulin 500IU solution for Injection (Bio Products Laboratory Limited) appeared first on Community Pharmacy England.

Pharmacy owners are reminded that the NHS Flu Vaccination Service ends on 31st March 2026. Pharmacy teams should not administer any further vaccinations under this service after this date. Pharmacy owners are reminded to ensure they have submitted their claims for payment for the service. These should be submitted within one month of, and no [...]

The post Reminder: Flu Vac Service 2025/26 ends appeared first on Community Pharmacy England.

Negotiations on the Community Pharmacy Contractual Framework (CPCF) arrangements for 2026/27 are still in progress between Community Pharmacy England, the Department of Health and Social Care (DHSC) and NHS England. Whilst all parties have been working hard on the negotiations, it is clear that they will not reach a conclusion before the start of the [...]

The post CPCF 2026/27: Ongoing negotiations mean no immediate changes appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (27/03/2026) confirmed the following list of price concessions for March 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post March 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 April 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Afatinib 20mg tablets Giotrif® 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet        [...]

The post 13 products re-classified as special containers from April 2026 appeared first on Community Pharmacy England.